Biocon's net profit doubles to Rs 172.7 crore in Q2 –

Indian pharmaceutical giant Biocon on Friday reported a net profit of Rs 172.7 crore in the September quarter of financial year 2023-24, more than double its profit of Rs 81.8 crore in the same period of the previous year. According to the compa

Related Keywords

Japan , United States , Australia , Bengaluru , Karnataka , India , New Zealand , America , American , Shreehas Tambe , Siddharth Mittal , Biocon Biologics , Jonathan Hunt , Manufacturing Services , Biocon , Biocon Ltd , Biocon Biologics Ltd , North America , Emerging Markets , Managing Director Siddharth Mittal , North American , Generic Formulations , Managing Director Shreehas Tambe , Managing Director Jonathan Hunt , Quality Control ,